Encompass Health (NYSE:EHC) Research Coverage Started at Deutsche Bank

Share on StockTwits

Deutsche Bank initiated coverage on shares of Encompass Health (NYSE:EHC) in a report released on Tuesday morning, Stock Target Advisor reports. The brokerage issued a hold rating and a $70.00 price objective on the stock.

Several other brokerages have also recently weighed in on EHC. BMO Capital Markets initiated coverage on Encompass Health in a research report on Thursday, June 27th. They set an outperform rating and a $72.00 price target on the stock. Barclays upgraded Encompass Health from an equal weight rating to an overweight rating and upped their price target for the company from $68.00 to $70.00 in a research report on Thursday, May 30th. Bank of America upgraded Encompass Health to a buy rating in a research report on Friday, September 6th. Finally, Raymond James decreased their price target on Encompass Health from $80.00 to $75.00 and set an outperform rating on the stock in a research report on Wednesday, July 31st. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The stock presently has a consensus rating of Buy and a consensus price target of $74.60.

NYSE EHC opened at $64.42 on Tuesday. The firm’s 50-day simple moving average is $62.21 and its two-hundred day simple moving average is $61.75. Encompass Health has a 52 week low of $56.74 and a 52 week high of $79.15. The company has a market cap of $6.27 billion, a PE ratio of 16.61, a price-to-earnings-growth ratio of 1.88 and a beta of 0.85. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 1.87.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Monday, July 29th. The company reported $1.08 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.97 by $0.11. Encompass Health had a return on equity of 24.10% and a net margin of 7.01%. The firm had revenue of $1.14 billion for the quarter, compared to analysts’ expectations of $1.13 billion. As a group, equities research analysts anticipate that Encompass Health will post 3.83 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 1st will be given a dividend of $0.28 per share. The ex-dividend date is Monday, September 30th. This is a boost from Encompass Health’s previous quarterly dividend of $0.27. This represents a $1.12 annualized dividend and a dividend yield of 1.74%. Encompass Health’s dividend payout ratio is currently 29.75%.

About Encompass Health

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Featured Story: Gap Down Stocks

Analyst Recommendations for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Adient  vs. ATC Venture Group  Critical Survey
Adient vs. ATC Venture Group Critical Survey
Kulicke and Soffa Industries  & GSI Technology  Head-To-Head Contrast
Kulicke and Soffa Industries & GSI Technology Head-To-Head Contrast
Steel Dynamics  Lowered to “Sell” at BidaskClub
Steel Dynamics Lowered to “Sell” at BidaskClub
BidaskClub Downgrades Patterson-UTI Energy  to Strong Sell
BidaskClub Downgrades Patterson-UTI Energy to Strong Sell
MTS Systems  Rating Increased to Sell at BidaskClub
MTS Systems Rating Increased to Sell at BidaskClub
Itron  Rating Increased to Strong-Buy at BidaskClub
Itron Rating Increased to Strong-Buy at BidaskClub


 
© 2006-2019 Zolmax.